Microba Life Sciences Limited
Microba Life Sciences Limited (MAP.AX) Stock Forecast & Price Predictions
Get the latest Microba Life Sciences Limited (MAP.AX) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.
Model Information
The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMonthly Forecast
Quarterly Forecast
Yearly Forecast
3 Years Forecast
5 Years Forecast
7 Years Forecast
Microba Life Sciences Limited Stock Forecast Summary
Microba Life Sciences Limited (MAP.AX) stock is currently priced at $0.07. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $0.07.
In the long term, MAP.AX shows a bearish trend. The 2027 forecast points to $0.02 (-69.74% change), while the 2031 forecast suggests $0.00 (-100.00% change). Looking 7 years ahead, projections estimate the stock could trade near $0.00, a -100.00% change from today’s price.
Neutral
Bullish
Bearish
This mix indicates that Microba Life Sciences Limited stock is expected to face downside risk over the coming years.
Investment Calculator
Estimate your potential returns on MAP.AX based on our AI price forecasts. Enter your investment amount and select a target date.
Based on your investment of $1,000.00 in Microba Life Sciences Limited and holding until April 5th, 2027, you could make a potential $697.36 loss, reflecting a -69.7% ROI over the next 365 days.
$Shares Bought
14,705.8824
@ $0.07/share
~Forecast Price
$0.02
1-year AI forecast
$Est. Portfolio Value
$302.64
$697.36 loss
%ROI
-69.7%
return on investment
Microba Life Sciences Limited yearly Price Forecast Chart
Explore the yearly forecast chart for MAP.AX, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Microba Life Sciences Limited over different timeframes.
No forecast data available
No prediction data found for this time period.
Forecasting data is not available for MAP.AXForecasting details for MAP.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.Microba Life Sciences Limited Stock Forecast 2026
The forecast for Microba Life Sciences Limited (MAP.AX) in 2026 suggests a price of $0.02, representing a -69.74% move from today’s price.
Average Target: $0.02
Market Outlook: bearish based on current trend indicators.
Key Drivers in 2026:- Earnings growth projections.
- Competitive performance in the Healthcare.
- Macroeconomic factors such as interest rates and inflation.